Literature DB >> 15183811

Photodynamic therapy for choroidal metastasis from carcinoid tumor.

J William Harbour1.   

Abstract

PURPOSE: To determine the efficacy of photodynamic therapy for the treatment of a choroidal metastasis unresponsive to chemotherapy and radiation therapy.
DESIGN: Interventional case report.
METHODS: Photodynamic therapy with verteporfin was performed. Visual acuity, local tumor control, and complications were assessed.
RESULTS: A 72-year-old woman was diagnosed with bilateral, biopsy-proven choroidal metastasis from a pulmonary carcinoid tumor that was resistant to chemotherapy and radiotherapy. The tumor in the left eye caused a retinal detachment and vision loss to light perception. The smaller lesion in the right eye progressively enlarged toward the fovea despite therapy and was treated with photodynamic therapy with verteporfin. Within 2 months, the exudative detachment resolved, the visual acuity returned to baseline, and the tumor volume decreased by 50%.
CONCLUSION: Photodynamic therapy may be an effective treatment option for selected patients with choroidal metastasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15183811     DOI: 10.1016/j.ajo.2004.01.009

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  14 in total

1.  Vision Loss from Choroidal and Pituitary Metastases Secondary to Renal Cell Carcinoma: A Case Report.

Authors:  Laura D Selby; Hillary C Stiefel; Alison H Skalet; Molly S Cardenal; Kavita V Bhavsar; Kimberly M Winges
Journal:  Neuroophthalmology       Date:  2018-06-19

Review 2.  Emerging treatments for choroidal metastases.

Authors:  Connie J Chen; Allison N McCoy; Julie Brahmer; James T Handa
Journal:  Surv Ophthalmol       Date:  2011 Nov-Dec       Impact factor: 6.048

3.  Ocular metastases.

Authors:  V M L Cohen
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

4.  The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation.

Authors:  Katarzyna Brodowska; Ahmad Al-Moujahed; Anna Marmalidou; Melissa Meyer Zu Horste; Joanna Cichy; Joan W Miller; Evangelos Gragoudas; Demetrios G Vavvas
Journal:  Exp Eye Res       Date:  2014-05-15       Impact factor: 3.467

5.  Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis.

Authors:  Saeed Karimi; Amir Arabi; Toktam Shahraki
Journal:  J Curr Ophthalmol       Date:  2020-12-12

Review 6.  Choroidal metastases: origin, features, and therapy.

Authors:  Sruthi Arepalli; Swathi Kaliki; Carol L Shields
Journal:  Indian J Ophthalmol       Date:  2015-02       Impact factor: 1.848

7.  Bilateral Choroidal Metastases from Lung Adenocarcinoma: A Case Report.

Authors:  Hasan Ergenc; Attila Onmez; Ezgi Oymak; Ramiser Tanriseven; Erkan Celik; Funda Ebru Onmez; Ali Tamer; Meltem Baykara
Journal:  Case Rep Oncol       Date:  2016-09-13

8.  Indocyanine green mediated photothrombosis and high dose intravitreal bevacizumab as adjuvant therapy for isolated choroidal metastasis from breast cancer.

Authors:  J Fernando Arevalo; Juan V Espinoza
Journal:  J Ophthalmic Vis Res       Date:  2012-10

9.  A case of presumed choroidal metastasis from carcinoid tumor treated by photodynamic therapy with verteporfin.

Authors:  Setsuko Kawakami; Yoshihiro Wakabayashi; Hiroshi Goto
Journal:  Clin Ophthalmol       Date:  2013-10-09

Review 10.  Photodynamic Therapy in Ocular Oncology.

Authors:  Maria Antonietta Blasi; Monica Maria Pagliara; Angela Lanza; Maria Grazia Sammarco; Carmela Grazia Caputo; Gabriela Grimaldi; Andrea Scupola
Journal:  Biomedicines       Date:  2018-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.